参考文献：
[1]Nair A , Lemery SJ , Yang J , Marathe A , Zhao L , Zhao H , Jiang X , He K , Ladouceur G , Mitra AK , Zhou L , Fox E , Aungst S , Helms W , Keegan P ,Pazdur R .Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Dec; 21 (23 ):5205-8.
[2]王凌霄,肖典,周辛波.口服多靶点酪氨酸激酶抑制剂——乐伐替尼[J].临床药物治疗杂志,2015,13(05):11-14.
[3]于悦,时静,刘玉国.乐伐替尼治疗恶性肿瘤的研究进展[J].中国医院药学杂志,2018,38(09):1005-1009.
[4]Nair A , Lemery SJ , Yang J , Marathe A , Zhao L , Zhao H , Jiang X , He K , Ladouceur G , Mitra AK , Zhou L , Fox E , Aungst S , Helms W , Keegan P ,Pazdur R .
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Dec; 21 (23 ):5205-8.
来源：康德乐大药房
